Onofrj M - Search Results

1

CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies.

Di Censo R, Abdelnour C, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Onofrj M, Aarsland D, Bonanni L; European DLB consortium. Di Censo R, et al. Among authors: onofrj m. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):109-110. doi: 10.1136/jnnp-2019-320980. Epub 2019 Jul 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 31366604 No abstract available.

2

Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine.

Onofrj M, Thomas A, Bonanni L, Iacono D, Gambi F. Onofrj M, et al. Neurol Sci. 2000 Aug;21(4):209-15. doi: 10.1007/s100720070078. Neurol Sci. 2000. PMID: 11214659

3

Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months.

Thomas A, Iacono D, Bonanni L, D'Andreamatteo G, Onofrj M. Thomas A, et al. Among authors: onofrj m. Clin Neuropharmacol. 2001 Jan-Feb;24(1):31-42. doi: 10.1097/00002826-200101000-00007. Clin Neuropharmacol. 2001. PMID: 11290880 Clinical Trial.

4

Switch-over from tolcapone to entacapone in severe Parkinson's disease patients.

Onofrj M, Thomas A, Iacono D, Di Iorio A, Bonanni L. Onofrj M, et al. Eur Neurol. 2001;46(1):11-6. doi: 10.1159/000050749. Eur Neurol. 2001. PMID: 11455177

5

Severe worsening of parkinsonism in Lewy body dementia due to donepezil.

Onofrj M, Thomas A. Onofrj M, et al. Neurology. 2003 Nov 25;61(10):1452. doi: 10.1212/01.wnl.0000094201.80888.da. Neurology. 2003. PMID: 14638981 No abstract available.

6

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Bonanni L, Thomas A, Onofrj M. Bonanni L, et al. Among authors: onofrj m. Neurology. 2006 May 9;66(9):1455; author reply 1455. doi: 10.1212/01.wnl.0000224698.67660.45. Neurology. 2006. PMID: 16682691 No abstract available.

7

Visual hallucinations in Parkinson's disease: clues to separate origins.

Onofrj M, Bonanni L, Albani G, Mauro A, Bulla D, Thomas A. Onofrj M, et al. J Neurol Sci. 2006 Oct 25;248(1-2):143-50. doi: 10.1016/j.jns.2006.05.025. Epub 2006 Jun 23. J Neurol Sci. 2006. PMID: 16806269 Review.

8

End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease.

Thomas A, Bonanni L, Di Iorio A, Varanese S, Anzellotti F, D'Andreagiovanni A, Stocchi F, Onofrj M. Thomas A, et al. Among authors: onofrj m. J Neurol. 2006 Dec;253(12):1633-9. doi: 10.1007/s00415-006-0320-z. J Neurol. 2006. PMID: 17219034 Clinical Trial.

9

Symptomatic REM sleep behaviour disorder.

Thomas A, Bonanni L, Onofrj M. Thomas A, et al. Among authors: onofrj m. Neurol Sci. 2007 Jan;28 Suppl 1:S21-36. doi: 10.1007/s10072-007-0735-y. Neurol Sci. 2007. PMID: 17235429

10

Dopa-responsive pseudo-orthostatic tremor in parkinsonism.

Thomas A, Bonanni L, Antonini A, Barone P, Onofrj M. Thomas A, et al. Among authors: onofrj m. Mov Disord. 2007 Aug 15;22(11):1652-6. doi: 10.1002/mds.21621. Mov Disord. 2007. PMID: 17579364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page